BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 6401303)

  • 1. Nonresponsiveness to the male antigen H-Y in H-2 I-A-mutant B6.C-H-2bm12 is not caused by defective antigen presentation.
    de Waal LP; de Hoop J; Stukart MJ; Gleichmann H; Melvold RW; Melief CJ
    J Immunol; 1983 Feb; 130(2):655-60. PubMed ID: 6401303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen and MHC restriction specificity of two types of cloned male-specific T cell lines.
    Tomonari K
    J Immunol; 1983 Oct; 131(4):1641-5. PubMed ID: 6194209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic T lymphocyte nonresponsiveness to the male antigen H-Y in the H-2Db mutants bm13 and bm14. Complementation of the response in F1 crosses with the I-Ab mutant bm12 nonresponder and failure of B6 or Db mutant mice tolerant of each other to respond to allogeneic male cells.
    De Waal LP; Melvold RW; Melief CJ
    J Exp Med; 1983 Nov; 158(5):1537-46. PubMed ID: 6415206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T lymphocyte response to minor H-42a alloantigen in H-42b mice: clonal inactivation of the precursor cytotoxic T lymphocytes by veto-like spleen cells that express the H-42a antigen.
    Ishikawa H; Hino T; Kato H; Suzuki H; Saito K
    J Immunol; 1986 Oct; 137(7):2080-8. PubMed ID: 3489752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helper effects required during in vivo priming for a cytolytic response to the H-Y antigen in nonresponder mice.
    Juretić A; Malenica B; Juretić E; Klein J; Nagy ZA
    J Immunol; 1985 Mar; 134(3):1408-14. PubMed ID: 2578505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of dendritic cells in the regulation of class I restricted cytotoxic T lymphocyte responses.
    Boog CJ; Boes J; Melief CJ
    J Immunol; 1988 May; 140(10):3331-7. PubMed ID: 2452183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
    Sato S; Azuma T; Shimizu J; Shima J; Kitagawa S; Hamaoka T; Fujiwara H
    J Immunol; 1988 Aug; 141(3):721-7. PubMed ID: 2456330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses.
    Boog CJ; Boes J; Melief CJ
    Eur J Immunol; 1988 Feb; 18(2):219-23. PubMed ID: 2965021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune recognition of insulin by H-2b mice: the mutation in the I-Ab beta gene of the B6.C-H-2bm12 mouse alters the self-I-A-restricted T cell repertoire.
    Hochman PS; Huber BT
    Eur J Immunol; 1984 Jul; 14(7):610-5. PubMed ID: 6204877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection from T helper cell-mediated graft-versus-host disease by the presence of an MHC class I alloantigen is associated with perturbation of MHC class II-restricted responses by class I-derived peptides.
    Leibnitz RR; Lipsky PE; Thiele DL
    J Immunol; 1995 Aug; 155(4):1784-95. PubMed ID: 7636234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell responses to select Ia determinants using the I-A mutant mouse strain B6.C-H-2bm12.
    Skelly RR; Pappas F; Koprak S; Ahmed A; Hansen TH
    J Immunol; 1982 Nov; 129(5):2094-7. PubMed ID: 6181160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two roles for CD4 cells in the control of the generation of cytotoxic T lymphocytes.
    Cassell D; Forman J
    J Immunol; 1991 Jan; 146(1):3-10. PubMed ID: 1670605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of the alloreactive T cell repertoire: K region homology between H-2b T cell precursors and T cell maturation environment is required for the generation of the Kbm6-specific cytotoxic T cell repertoire.
    Gress RE; Hodes RJ
    J Immunol; 1984 May; 132(5):2226-31. PubMed ID: 6201535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of cytotoxic T cells specific for minor histocompatibility antigens by cross challenge in vitro with H-2 disparate adherent cells.
    Pilarski LM; Carayanniotis G
    J Immunol; 1985 Dec; 135(6):3686-90. PubMed ID: 2415580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective reversal of H-2-linked genetic unresponsiveness to lysozymes. II. Alteration in the T helper/T suppressor balance, owing to gene(s) linked to Ir-2, leads to responsiveness in BALB.B.
    Sadegh-Nasseri S; Dessi V; Sercarz EE
    Eur J Immunol; 1986 May; 16(5):486-92. PubMed ID: 2938974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
    J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.